Estudo lança dúvidas sobre a diretriz da OMS quanto ao uso de antibióticos na sepse neonatal.

Study casts doubt on WHO guidance on antibiotics for neonatal sepsis – CIDRAP

Estudo original: Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS) – The Lancet Infectious Diseases

Comentário convidado: Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here? (necessário cadastro gratuito)

Comentário no Twitter

"WHO recommends ampicillin in combination with gentamicin for the management of clinical neonatal sepsis; however, there are persistent concerns regarding antimicrobial resistance and therapeutic failures with this treatment" #PIDTwitter #IDTwitter #medtwitter #TwitteRx https://t.co/FDlXwugouU

— Antibiotic Steward 🆔🇵🇸 Bassam Ghanem (@ABsteward) August 9, 2021